Two Cases of Miliary and Disseminated Coccidioidomycosis Following Glucocorticoid Therapy and Literature Review.
Rowis SousYuliya LevkiavskaRupam SharmaRoopam JariwalDaniela AmodioRoyce H JohnsonArash HeidariRasha KuranPublished in: Journal of investigative medicine high impact case reports (2022)
A 49-year-old man with no significant past medical history received dexamethasone as part of his treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Less than 3 weeks later, the patient developed acute respiratory distress syndrome. Radiological and serological testing led to a diagnosis of acute hypoxic miliary coccidioidomycosis. A 52-year-old man with a past medical history of chronic kidney disease (CKD) was treated with prednisone for focal segmental glomerulosclerosis (FSGS). Within 2 weeks, this patient developed bilateral lower extremity weakness. Radiology, serology, and lumbar puncture proved a diagnosis of reactivated coccidioidomycosis with miliary pattern and coccidioidomycosis meningoencephalitis with arachnoiditis. Whether treatment with glucocorticoids caused reactivation of coccidioidomycosis is discussed in this case series.
Keyphrases
- acute respiratory distress syndrome
- respiratory syndrome coronavirus
- chronic kidney disease
- case report
- healthcare
- sars cov
- extracorporeal membrane oxygenation
- low dose
- liver failure
- minimally invasive
- coronavirus disease
- artificial intelligence
- stem cells
- high dose
- machine learning
- deep learning
- smoking cessation
- ultrasound guided
- chemotherapy induced